155 related articles for article (PubMed ID: 26363899)
1. Lack of ethnic differences in the pharmacokinetics and pharmacodynamics of inclacumab in healthy Japanese and Caucasian subjects.
Morrison M; Palermo G; Schmitt C
Eur J Clin Pharmacol; 2015 Nov; 71(11):1365-74. PubMed ID: 26363899
[TBL] [Abstract][Full Text] [Related]
2. First-in-Man Study With Inclacumab, a Human Monoclonal Antibody Against P-selectin.
Schmitt C; Abt M; Ciorciaro C; Kling D; Jamois C; Schick E; Solier C; Benghozi R; Gaudreault J
J Cardiovasc Pharmacol; 2015 Jun; 65(6):611-9. PubMed ID: 25714598
[TBL] [Abstract][Full Text] [Related]
3. A phase 1 study in healthy participants to characterize the safety and pharmacology of inclacumab, a fully human anti-P-selectin antibody, in development for treatment of sickle cell disease.
Mayer CL; Koeck K; Hottmann M; Redfern A; Davis M; Barth A; Geng X; Hoppe C; Yue P
Eur J Clin Pharmacol; 2023 Sep; 79(9):1219-1228. PubMed ID: 37436495
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab--preclinical and clinical studies.
Kling D; Stucki C; Kronenberg S; Tuerck D; Rhéaume E; Tardif JC; Gaudreault J; Schmitt C
Thromb Res; 2013 May; 131(5):401-10. PubMed ID: 23522853
[TBL] [Abstract][Full Text] [Related]
5. Absence of pharmacodynamic interaction between inclacumab and heparin in healthy smokers.
Schmitt C; Mudie N; Ciorciaro C; Gaudreault J
J Cardiovasc Pharmacol; 2015 Apr; 65(4):386-92. PubMed ID: 25602360
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of serelaxin, a recombinant human relaxin-2 in development for the treatment of acute heart failure, in healthy Japanese volunteers and a comparison of pharmacokinetics and pharmacodynamics in healthy Japanese and Caucasian populations.
Dahlke M; Ng D; Yamaguchi M; Machineni S; Berger S; Canadi J; Rajman I; Lloyd P; Pang Y
J Clin Pharmacol; 2015 Apr; 55(4):415-22. PubMed ID: 25408331
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, safety and tolerability of rotigotine transdermal patch in healthy Japanese and Caucasian subjects.
Cawello W; Kim SR; Braun M; Elshoff JP; Ikeda J; Funaki T
Clin Drug Investig; 2014 Feb; 34(2):95-105. PubMed ID: 24178238
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of the antiepileptic drug levetiracetam in healthy Japanese and Caucasian volunteers following intravenous administration.
Toublanc N; Okagaki T; Boyce M; Chan R; Mugitani A; Watanabe S; Yamamoto K; Yoshida K; Andreas JO
Eur J Drug Metab Pharmacokinet; 2015 Dec; 40(4):461-9. PubMed ID: 25283522
[TBL] [Abstract][Full Text] [Related]
9. Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial.
Tardif JC; Tanguay JF; Wright SR; Duchatelle V; Petroni T; Grégoire JC; Ibrahim R; Heinonen TM; Robb S; Bertrand OF; Cournoyer D; Johnson D; Mann J; Guertin MC; L'Allier PL
J Am Coll Cardiol; 2013 May; 61(20):2048-55. PubMed ID: 23500230
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, Pharmacodynamics, and Safety of Peficitinib (ASP015K) in Healthy Male Caucasian and Japanese Subjects.
Shibata M; Hatta T; Saito M; Toyoshima J; Kaneko Y; Oda K; Nishimura T
Clin Drug Investig; 2020 May; 40(5):469-484. PubMed ID: 32274653
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of intravenous and inhaled fluticasone furoate in healthy Caucasian and East Asian subjects.
Allen A; Bal J; Cheesbrough A; Hamilton M; Kempsford R
Br J Clin Pharmacol; 2014 May; 77(5):808-20. PubMed ID: 24152086
[TBL] [Abstract][Full Text] [Related]
12. Effects of ethnicity and sex on the pharmacokinetics and pharmacodynamics of the selective sphingosine-1-phosphate receptor 1 modulator ponesimod: a clinical study in Japanese and Caucasian subjects.
Reyes M; Hoch M; Brossard P; Dingemanse J
Pharmacology; 2014; 94(5-6):223-9. PubMed ID: 25402365
[TBL] [Abstract][Full Text] [Related]
13. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Atacicept in a Randomized Trial in Healthy Caucasian and Japanese Subjects.
Willen D; Uhl W; Wolna P; Papasouliotis O; Yalkinoglu Ö
Eur J Drug Metab Pharmacokinet; 2020 Feb; 45(1):27-40. PubMed ID: 31529406
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and safety of Enasidenib following single oral doses in Japanese and Caucasian subjects.
Li Y; Liu L; Gomez D; Chen J; Tong Z; Palmisano M; Zhou S
Pharmacol Res Perspect; 2018 Dec; 6(6):e00436. PubMed ID: 30386625
[TBL] [Abstract][Full Text] [Related]
15. Tildrakizumab, a novel anti-IL-23 monoclonal antibody, is unaffected by ethnic variability in Caucasian, Chinese, and Japanese subjects.
Zandvliet A; Glasgow S; Horowitz A; Montgomery D; Marjason J; Mehta A; Xu C; van Vugt M; Khalilieh S
Int J Clin Pharmacol Ther; 2015 Feb; 53(2):139-46. PubMed ID: 25546162
[TBL] [Abstract][Full Text] [Related]
16. Lack of racial differences in the pharmacokinetics of subcutaneous golimumab in healthy Japanese and Caucasian male subjects.
Ling J; Lyn S; Xu Z; Achira M; Bouman-Thio E; Shishido A; Ford J; Shankar G; Wagner C; Kim KT; Davis HM; Zhou H
J Clin Pharmacol; 2010 Jul; 50(7):792-802. PubMed ID: 20133508
[TBL] [Abstract][Full Text] [Related]
17. No differences in the pharmacodynamics and pharmacokinetics of the thrombin receptor antagonist vorapaxar between healthy Japanese and Caucasian subjects.
Kosoglou T; Reyderman L; Kasserra C; Jennings LK; Young S; Xuan F; Pei J; Maxwell SE; Schiller J; Meehan AG; Cutler DL
Eur J Clin Pharmacol; 2012 Mar; 68(3):291-300. PubMed ID: 21969227
[TBL] [Abstract][Full Text] [Related]
18. First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjects.
Perera V; Luettgen JM; Wang Z; Frost CE; Yones C; Russo C; Lee J; Zhao Y; LaCreta FP; Ma X; Knabb RM; Seiffert D; DeSouza M; Mugnier P; Cirincione B; Ueno T; Frost RJA
Br J Clin Pharmacol; 2018 May; 84(5):876-887. PubMed ID: 29346838
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, safety, and tolerability of rotigotine transdermal system in healthy Japanese and Caucasian subjects following multiple-dose administration.
Cawello W; Kim SR; Braun M; Elshoff JP; Masahiro T; Ikeda J; Funaki T
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):353-62. PubMed ID: 25773763
[TBL] [Abstract][Full Text] [Related]
20. Safety, pharmacokinetics and pharmacodynamics of four-hour intravenous infusions of eritoran in healthy Japanese and Caucasian men.
Aikawa N; Okubo Y; Lynn M; Rossignol DP; Wong YN; Schuck E; Kitahara Y; Nakano T; Sivak O; Wasan KM; Nagy C; Yen M
Innate Immun; 2012 Dec; 18(6):793-803. PubMed ID: 22459966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
